Cargando…
Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer
BACKGROUND: Histone lysine lactylation (Kla) is a newly identified histone modification, which plays a crucial role in cancer progression. Hence, we determined the prognostic value of Kla in breast cancer (BC). METHODS: We obtained RNA expression profiles of BC from The Cancer Genome Atlas (TCGA), f...
Autores principales: | Deng, Jian, Liao, Xinyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636881/ https://www.ncbi.nlm.nih.gov/pubmed/37950222 http://dx.doi.org/10.1186/s12920-023-01726-1 |
Ejemplares similares
-
Integrated analysis of histone lysine lactylation (Kla)-specific genes suggests that NR6A1, OSBP2 and UNC119B are novel therapeutic targets for hepatocellular carcinoma
por: Wu, Qinjuan, et al.
Publicado: (2023) -
FSL-Kla: A few-shot learning-based multi-feature hybrid system for lactylation site prediction
por: Jiang, Peiran, et al.
Publicado: (2021) -
Identification of lysine-lactylated substrates in gastric cancer cells
por: Yang, Dawei, et al.
Publicado: (2022) -
Comprehensive analysis of lysine lactylation in Frankliniella occidentalis
por: An, Dong, et al.
Publicado: (2022) -
Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma
por: Han, Ik-Hwan, et al.
Publicado: (2022)